Quantbot Technologies’s GSK GSK Stock Holding History

Quantbot Technologies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-38,497	Closed	-$1.89M	–	1889
2025 Q4	$1.89M	Buy	38,497 +15,100	+65%	+$704K	0.06%	469
2025 Q3	$1.01M	Sell	23,397 -115,501	-83%	-$4.51M	0.03%	769
2025 Q2	$5.33M	Buy	138,898 +90,097	+185%	+$3.44M	0.14%	193
2025 Q1	$1.89M	Sell	48,801 -40,570	-45%	-$1.49M	0.06%	472
2024 Q4	$3.02M	Sell	89,371 -121,439	-58%	-$4.37M	0.11%	278
2024 Q3	$8.62M	Buy	210,810 +184,204	+692%	+$7.54M	0.34%	48
2024 Q2	$1.02M	Sell	26,606 -17,950	-40%	-$755K	0.05%	534
2024 Q1	$1.91M	Sell	44,556 -100,156	-69%	-$4.13M	0.11%	292
2023 Q4	$5.36M	Buy	+144,712	New	+$5.2M	0.31%	59
2023 Q3	–	Sell	-34,539	Closed	-$1.23M	–	1713
2023 Q2	$1.23M	Buy	+34,539	New	+$1.24M	0.08%	386
2023 Q1	–	Sell	-45,911	Closed	-$1.61M	–	1748
2022 Q4	$1.61M	Sell	45,911 -42,146	-48%	-$1.4M	0.12%	261
2022 Q3	$2.59M	Buy	+88,057	New	+$3.34M	0.2%	157
2022 Q2	–	Sell	-39,751	Closed	-$2.16M	–	1859
2022 Q1	$2.16M	Buy	+39,751	New	+$2.16M	0.19%	141
2021 Q2	–	Sell	-37,160	Closed	-$1.66M	–	1600
2021 Q1	$1.66M	Sell	37,160 -27,468	-43%	-$1.25M	0.16%	177
2020 Q4	$2.97M	Buy	64,628 +52,538	+435%	+$2.41M	0.31%	91
2020 Q3	$568K	Buy	12,090 +7,110	+143%	+$356K	0.07%	322
2020 Q2	$253K	Buy	4,980 +2,375	+91%	+$122K	0.03%	371
2020 Q1	$123K	Buy	+2,605	New	+$139K	0.08%	290
2018 Q3	–	Sell	-12,890	Closed	-$649K	–	1361
2018 Q2	$649K	Buy	+12,890	New	+$649K	0.04%	508
2018 Q1	–	Sell	-11,634	Closed	-$515K	–	1327
2017 Q4	$515K	Buy	+11,634	New	+$537K	0.05%	491
2017 Q3	–	Sell	-102,370	Closed	-$5.52M	–	1277
2017 Q2	$5.52M	Buy	+102,370	New	+$5.46M	0.52%	33
2017 Q1	–	Sell	-38,405	Closed	-$1.85M	–	1238
2016 Q4	$1.85M	Buy	+38,405	New	+$1.9M	0.2%	113
2016 Q3	–	Sell	-55,073	Closed	-$2.98M	–	1165
2016 Q2	$2.98M	Buy	55,073 +6,812	+14%	+$359K	0.32%	87
2016 Q1	$2.45M	Sell	48,261 -26,586	-36%	-$1.32M	0.39%	49
2015 Q4	$3.77M	Buy	+74,847	New	+$3.82M	0.65%	25
2015 Q2	–	Sell	-22,234	Closed	-$1.28M	–	1210
2015 Q1	$1.28M	Buy	+22,234	New	+$1.27M	0.32%	84
2014 Q4	–	Sell	-34,765	Closed	-$2M	–	1234
2014 Q3	$2M	Sell	34,765 -5,785	-14%	-$355K	0.27%	95
2014 Q2	$2.71M	Buy	40,550 +14,214	+54%	+$962K	0.43%	45
2014 Q1	$1.76M	Buy	+26,336	New	+$1.78M	0.41%	53
2013 Q4	–	Sell	-5,182	Closed	-$324K	–	1055
2013 Q3	$324K	Buy	+5,182	New	+$334K	0.2%	135

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quantbot Technologies's GSK Position: Q1 2026 in Review

Quantbot Technologies sold out of GSK (GSK) in Q1 2026, closing a stake of 38,497 shares — an estimated $1.89M sold.

Quantbot Technologies first reported a position in GSK in Q3 2013 and held it in 30 quarters. The position peaked at $8.62M in Q3 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Quantbot Technologies reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Quantbot Technologies sold 38,497 GSK shares in Q1 2026, an estimated $1.89M.
Quantbot Technologies first reported a position in GSK in Q3 2013 and held it in 30 quarters.
Quantbot Technologies's GSK position peaked at $8.62M in Q3 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.